The Board of Directors of KYMOS is formed by a team experienced members with an relevant track record in different fields, but specially in pharma companies. In accordance with KYMOS’s Articles of Association, the Board comprises between three and seven members. At this moment the Board is formed by 4 Directors and a Secretary. The Board has established quarterly ordinary meetings plus extraordinary meetings, when necessary. Usually, the management respresented by the C-Levels (CEO, COO and CFO) are also present in the Board meetings as Coopoted members. The Board brings a constructive contribution to the strategic discussions and the governance of the company and the dialog conducted between the Board members and management is very productive. The Board is also responsible for the appointment of the company auditors.